Jci_page_head_homepage_01 Jci_page_head_homepage_02
Peggy C.R. Godschalk, Astrid P. Heikema, Michel Gilbert, Tomoko Komagamine, C. Wim Ang, Jobine Glerum, Denis Brochu, Jianjun Li, Nobuhiro Yuki, Bart C. Jacobs, Alex van Belkum, Hubert P. Endtz
Published in Volume 114, Issue 11
J Clin Invest. 2004; 114(11):1659–1665 doi:10.1172/JCI15707
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 5

Anti-glycolipid antibodies in serum of mice before and after immunization with WT and mutant GB11 C. jejuni strains. (A and D) When sialic acid was present on the LOS core (WT and orf11 mutant), anti-GD1a antibodies were induced in mice. (B and C) Anti-GD1a antibody responses were not detected in mice immunized with nonsialylated LOS (cst-II and orf10/orf11 mutants). (F and G) Nonsialylated LOS (cst-II and orf10/orf11 mutants) induced high asialo-GM1 antibody responses. (E and H) Asialo-GM1 antibody responses were absent or low after immunization with the orf11 mutant and WT.